Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lucie, Nekvindová"'
Autor:
Lucie Nekvindová, Jiří Vencovský, Karel Pavelka, Pavel Horák, Zlatuše Křístková, Jakub Závada
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Background Treat-to-target (T2T) is a widely accepted strategy for patients with rheumatoid arthritis (RA). It recommends attaining a goal of at least low disease activity (LDA) within 6 months; otherwise, the current therapy should be modif
Externí odkaz:
https://doaj.org/article/cdac019808f04a84af01b113280dc57e
Autor:
Martina, Skácelová, Lucie, Nekvindová, Heřman, Mann, Jakub, Závada, Zlatuše, Křístková, Jiří, Vencovský, Karel, Pavelka, Pavel, Horák
Publikováno v:
Rheumatology International. 42:803-814
The study aimed to compare treatment retention for first-line TNF inhibitor (TNFi) in the ATTRA registry patients receiving either combination with conventional synthetic DMARDs or TNFi as monotherapy. A retrospective multicenter study analyzed data
Autor:
Johan Askling, Burkhard Möller, Matija Tomšič, Lennart T H Jacobsson, Jakub Zavada, Thorvardur Jon Love, Daniela Di Giuseppe, Adrian Ciurea, Manuel Pombo-Suarez, Maria José Santos, Bjorn Gudbjornsson, Pedro Avila-Ribeiro, Catalin Codreanu, Brigitte Michelsen, Michael John Nissen, Carlos Sánchez-Piedra, Lykke Midtbøll Ørnbjerg, Karen Minde Fagerli, Bente Glintborg, Žiga Rotar, Bénédicte Delcoigne, Gareth T. Jones, Ruxandra Ionescu, Servet Yolbas, Ulf Lindström, Lucie Nekvindová, Heikki Relas, Mikkel Østergaard, Nuh Atas, Florenzo Iannone, Kari K. Eklund
Publikováno v:
Annals of the Rheumatic Diseases
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with
Background: Patient-reported outcomes (PROs) have been shown to predict various disease outcomes. One of the most widely used PRO instruments is the Short Form (SF) 36 questionnaire which evaluates the patient's health status. Our goal was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b2d36703586b1a8a7bd196b6dc806e7
https://doi.org/10.21203/rs.3.rs-1643221/v1
https://doi.org/10.21203/rs.3.rs-1643221/v1
Autor:
Hynek Poul, Šárka Pospíšilová, Eva Koriťáková, Jan Novák, Michael Doubek, Lukas Smolej, Lucie Nekvindová, Lucie Němcová, Martin Spacek, Jana Zuchnická, Daniel Lysák, Karla Plevová, Filip Vrbacký, Renata Urbanova, Tomas Papajik, Yvona Brychtová, Stanislava Mašlejová, David Starostka, Martin Brejcha, Martin Simkovic, Pavel Vodárek, Anna Panovská
Publikováno v:
Hematological Oncology. 38:509-516
Until recently, a combination of anti-CD20 antibody plus less intensive chemotherapy was a standard of care in elderly population with previously untreated chronic lymphocytic leukemia (CLL). The aim of this observational study was to retrospectively
Autor:
Irene E. van der Horst-Bruinsma, Manuel Pombo-Suarez, Tore K Kvien, Helena Santos, Johan K. Wallman, Sema Yilmaz, Ruxandra Ionescu, Lucie Nekvindová, Nina Trokovic, Kari K. Eklund, Maria José Santos, Ennio Giulio Favalli, Bjorn Gudbjornsson, Stylianos Georgiadis, Gareth T. Jones, Yavuz Pehlivan, Merete Lund Hetland, Florenzo Iannone, Carlos Sánchez-Piedra, Catalin Codreanu, Eirik Kristianslund, Anne Gitte Loft, Daniela Di Giuseppe, Ziga Rotar, Matija Tomšič, Brigitte Michelsen, Mikkel Østergaard, Burkhard Möller, Lykke Midtbøll Ørnbjerg, Michael John Nissen, Cecilie Heegaard Brahe, Herman Mann, Thorvardur Jon Love
Publikováno v:
Michelsen, B, Georgiadis, S, Di Giuseppe, D, Loft, A G, Nissen, M J, Iannone, F, Pombo-Suarez, M, Mann, H, Rotar, Z, Eklund, K K, Kvien, T K, Santos, M J, Gudbjornsson, B, Codreanu, C, Yilmaz, S, Wallman, J K, Brahe, C H, Möller, B, Favalli, E G, Sánchez-Piedra, C, Nekvindova, L, Tomsic, M, Trokovic, N, Kristianslund, E K, Santos, H, Löve, T J, Ionescu, R, Pehlivan, Y, Jones, G T, van der Horst-Bruinsma, I, Ørnbjerg, L M, Østergaard, M & Hetland, M L 2022, ' Real-World Six-and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries ', Arthritis Care and Research, vol. 74, no. 7, pp. 1205-1218 . https://doi.org/10.1002/acr.24560
Arthritis Care & Research, 74, 7, pp. 1205-1218
Arthritis Care & Research, 74, 1205-1218
Arthritis Care & Research, 74, 7, pp. 1205-1218
Arthritis Care & Research, 74, 1205-1218
Contains fulltext : 251829.pdf (Publisher’s version ) (Open Access) OBJECTIVE: There is a lack of real-life studies on interleukin-17 (IL-17) inhibition in psoriatic arthritis (PsA). We assessed real-life 6- and 12-month effectiveness (i.e., retent
Autor:
Jakub Zavada, Lucie Nekvindová, Karel Pavelka, Zlatuše Křístková, Jiří Vencovský, Pavel Horák
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
BackgroundTreat-to-target (T2T) is a widely accepted strategy for patients with rheumatoid arthritis (RA). It recommends attaining a goal of at least low disease activity (LDA) within 6 months; otherwise, the current therapy should be modified. We ai
Autor:
null Anna Panovská, null Lucie NĚmcová, null Lucie Nekvindová, null Martin Špaček, null Martin Šimkovič, null Tomáš Papajík, null Martin Brejcha, null Daniel Lysák, null Jana Zuchnická, null Jan Novák, null David Starostka, null Hynek Poul, null Filip Vrbacký, null Pavel Vodárek, null Renata Urbanová, null Karla Plevová, null Šárka Pospíšilová, null Stanislava Mašlejová, null Yvona Brychtová, null Eva KoriŤáková, null Lukáš Smolej, null Michael Doubek
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::923987ac4cdea213cf6b2db9b46e13d7
https://doi.org/10.1002/hon.2744/v2/response1
https://doi.org/10.1002/hon.2744/v2/response1
Autor:
Anna, Panovská, Lucie, Němcová, Lucie, Nekvindová, Martin, Špaček, Martin, Šimkovič, Tomáš, Papajík, Martin, Brejcha, Daniel, Lysák, Jana, Zuchnická, Jan, Novák, David, Starostka, Hynek, Poul, Filip, Vrbacký, Pavel, Vodárek, Renata, Urbanová, Karla, Plevová, Šárka, Pospíšilová, Stanislava, Mašlejová, Yvona, Brychtová, Eva, Koriťáková, Lukáš, Smolej, Michael, Doubek
Publikováno v:
Hematological oncologyREFERENCES. 38(4)
Until recently, a combination of anti-CD20 antibody plus less intensive chemotherapy was a standard of care in elderly population with previously untreated chronic lymphocytic leukemia (CLL). The aim of this observational study was to retrospectively
Autor:
Jason Gotlib, Patrizia Bonadonna, Nadja Jäkel, Karoline V. Gleixner, Massimo Triggiani, Lucie Nekvindová, Luca Malcovati, Hanneke Oude Elberink, Akif Selim Yavuz, Mattias Mattsson, Roberta Parente, Andreas Reiter, Nikolas von Bubnoff, Karin Hartmann, Olivier Hermine, Roberta Zanotti, Michel Arock, Anja Illerhaus, Knut Brockow, Alexander Zink, Magdalena Lange, Massimiliano Bonifacio, Hanneke C. Kluin-Nelemans, Michael Doubek, Anna Belloni Fortina, Jiri Mayer, Alex Kilbertus, Khalid Shoumariyeh, Aleksandra Górska, Vito Sabato, Jens Panse, David Fuchs, Hans Hägglund, Wolfgang R. Sperr, Peter Valent, Chiara Elena, Bjorn van Anrooij, Marek Niedoszytko, Mohamad Jawhar, Francesca Caroppo, Cecelia Perkins, Jakub Trizuljak, Agnes Bretterklieber
Publikováno v:
Allergy: European journal of allergy and clinical immunology
Allergy, 75(8), 1927-1938. Wiley-Blackwell
Allergy
Allergy, 75(8), 1927-1938. Wiley-Blackwell
Allergy
Background: In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable